About the Surveillance Research Program


SRP provides national leadership in the science of cancer surveillance as well as analytical tools and methodological expertise in collecting, analyzing, interpreting, and disseminating reliable population-based cancer statistics. This surveillance infrastructure benefits the public, policymakers, and scientists in understanding changes in cancer incidence and outcomes in all segments of the US population over time.

About the Surveillance Research Program

SRP comprises the Office of the Associate Director and four branches: Data Analytics, Data Quality, Analysis, and Interpretation, Statistical Research and Applications, and Surveillance Informatics.

Learn more about the branches' areas of focus and view a listing of our staff.

What is Cancer Surveillance?

Cancer surveillance provides a quantitative portrait of cancer and its determinants in a defined population. The core functions of cancer surveillance are the measurement of cancer incidence, morbidity, survival, and mortality for persons with cancer. It also includes the assessment of genetic predisposition, environmental and behavioral risk factors, screening practices, and the quality of care from prevention through palliation. Cancer surveillance tells us where we are in the effort to reduce the cancer burden and also generates the observations that form the basis for cancer research and interventions for cancer prevention and control.

Toward Precision Cancer Surveillance Blog

Updates about initiatives that the Surveillance Research Program (SRP) is spearheading to bring the nation closer to a complete and detailed understanding of the cancer burden. The blog's commentaries report on key collaborations and other efforts that aim to build an increasingly powerful and useful cancer surveillance infrastructure. We also highlight methods and technologies that are and will be essential for rapidly collecting, analyzing, interpreting, sharing, and applying cancer surveillance data.

Visit the Blog


Last Updated: 02 Jan, 2020